IL149779A0 - A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias - Google Patents

A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias

Info

Publication number: IL149779A0
Authority: IL; Israel
Prior art keywords: prostate; vaccine; hyperplasias; lactobacilli; inflammation
Prior art date: 1999-11-25

Application number

IL14977900A

Other languages

English (en)

Original Assignee

Vakcina Kft

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-25

Filing date

2000-11-23

Publication date

2002-11-10

2000-11-23 Application filed by Vakcina Kft filed Critical Vakcina Kft

2002-11-10 Publication of IL149779A0 publication Critical patent/IL149779A0/xx

Links

229960005486 vaccine Drugs 0.000 title abstract 3
206010004446 Benign prostatic hyperplasia Diseases 0.000 title abstract 2
206010061218 Inflammation Diseases 0.000 title abstract 2
241000186660 Lactobacillus Species 0.000 title abstract 2
230000004054 inflammatory process Effects 0.000 title abstract 2
210000002307 prostate Anatomy 0.000 title abstract 2
239000000969 carrier Substances 0.000 abstract 1
229940039696 lactobacillus Drugs 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Mycology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Endocrinology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IL14977900A 1999-11-25 2000-11-23 A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias IL149779A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HU9904408A HU227086B1 (en)	1999-11-25	1999-11-25	Lactobacillus vaccine for treating prostata inflammatory and benign prostata hyperplasia
PCT/HU2000/000122 WO2001037862A2 (fr)	1999-11-25	2000-11-23	Vaccin a base de lactobacilles pour le traitement des inflammations de la prostate et de l'hyperplasie benigne de la prostate

Publications (1)

Publication Number	Publication Date
IL149779A0 true IL149779A0 (en)	2002-11-10

Family

ID=90014600

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL14977900A IL149779A0 (en)	1999-11-25	2000-11-23	A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias
IL149779A IL149779A (en)	1999-11-25	2002-05-21	Vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias and its production

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL149779A IL149779A (en)	1999-11-25	2002-05-21	Vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias and its production

Country Status (20)

Country	Link
US (4)	US20080175865A1 (fr)
EP (1)	EP1272216B1 (fr)
AT (1)	ATE470452T1 (fr)
AU (1)	AU779214B2 (fr)
CA (1)	CA2394843C (fr)
CZ (1)	CZ302662B6 (fr)
DE (1)	DE60044539D1 (fr)
DK (1)	DK1272216T3 (fr)
EA (1)	EA005198B1 (fr)
ES (1)	ES2348591T3 (fr)
HU (1)	HU227086B1 (fr)
IL (2)	IL149779A0 (fr)
PL (1)	PL201804B1 (fr)
PT (1)	PT1272216E (fr)
RO (1)	RO122760B1 (fr)
RS (1)	RS51201B (fr)
SI (1)	SI20960B (fr)
SK (1)	SK288132B6 (fr)
UA (1)	UA78673C2 (fr)
WO (1)	WO2001037862A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1723965A1 (fr) *	2005-05-18	2006-11-22	Stallergenes Sa	Compositions pour l'induction de tolerance immunologique specifique à des antigènes à travers de la immunization orale
US9732131B2 (en)	2006-02-27	2017-08-15	Calviri, Inc.	Identification and use of novopeptides for the treatment of cancer
US20110027348A1 (en)	2007-08-27	2011-02-03	Janos Feher	Composition and method inhibiting inflammation
JP2020522479A (ja)	2017-06-02	2020-07-30	アリゾナボードオブリージェンツオンビハーフオブアリゾナステートユニバーシティ	個別化された癌ワクチンを作製する方法
US12025615B2 (en)	2017-09-15	2024-07-02	Arizona Board Of Regents On Behalf Of Arizona State University	Methods of classifying response to immunotherapy for cancer
JP7303811B2 (ja) *	2017-12-19	2023-07-05	デュポンニュートリションバイオサイエンシーズエーピーエス	認知的及び精神的健康のためのプロバイオティクス
WO2021067550A1 (fr)	2019-10-02	2021-04-08	Arizona Board Of Regents On Behalf Of Arizona State University	Procédés et compositions pour identifier des néo-antigènes destinés à être utilisés dans le traitement et la prévention du cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH639280A5 (de) *	1977-12-23	1983-11-15	Solco Basel Ag	Verfahren zur herstellung einer vakzine gegen das trichomonas-syndrom.
DE19522472C2 (de) *	1995-06-21	1998-07-02	Eugen Baumgaertner	Herstellungsverfahren eines Fermentationsproduktes zur Behandlung von Prostataleiden
GB2338245B (en) *	1997-08-21	2001-11-21	New Zealand Dairy Board	Immunity enhancing lactic acid bacteria
IT1298918B1 (it) *	1998-02-20	2000-02-07	Mendes Srl	Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
IT1306716B1 (it) *	1999-06-21	2001-10-02	Mendes S U R L	Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.

1999
- 1999-11-25 HU HU9904408A patent/HU227086B1/hu unknown
2000
- 2000-11-23 DE DE60044539T patent/DE60044539D1/de not_active Expired - Lifetime
- 2000-11-23 DK DK00981507.7T patent/DK1272216T3/da active
- 2000-11-23 ES ES00981507T patent/ES2348591T3/es not_active Expired - Lifetime
- 2000-11-23 EP EP00981507A patent/EP1272216B1/fr not_active Expired - Lifetime
- 2000-11-23 CA CA2394843A patent/CA2394843C/fr not_active Expired - Fee Related
- 2000-11-23 WO PCT/HU2000/000122 patent/WO2001037862A2/fr not_active Ceased
- 2000-11-23 IL IL14977900A patent/IL149779A0/xx unknown
- 2000-11-23 PL PL355886A patent/PL201804B1/pl unknown
- 2000-11-23 RO ROA200200663A patent/RO122760B1/ro unknown
- 2000-11-23 UA UA2002064624A patent/UA78673C2/uk unknown
- 2000-11-23 RS YUP-374/02A patent/RS51201B/sr unknown
- 2000-11-23 SI SI200020063A patent/SI20960B/sl active Search and Examination
- 2000-11-23 CZ CZ20021771A patent/CZ302662B6/cs not_active IP Right Cessation
- 2000-11-23 SK SK738-2002A patent/SK288132B6/sk not_active IP Right Cessation
- 2000-11-23 AT AT00981507T patent/ATE470452T1/de active
- 2000-11-23 AU AU18741/01A patent/AU779214B2/en not_active Ceased
- 2000-11-23 EA EA200200602A patent/EA005198B1/ru not_active IP Right Cessation
- 2000-11-23 PT PT00981507T patent/PT1272216E/pt unknown
2002
- 2002-05-21 IL IL149779A patent/IL149779A/en not_active IP Right Cessation
2008
- 2008-03-21 US US12/077,780 patent/US20080175865A1/en not_active Abandoned
2011
- 2011-03-16 US US13/049,344 patent/US9056073B2/en not_active Expired - Fee Related
2015
- 2015-06-10 US US14/735,637 patent/US20160051657A1/en not_active Abandoned
2018
- 2018-02-08 US US15/891,620 patent/US20180161414A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20180161414A1 (en)	2018-06-14
SK7382002A3 (en)	2002-11-06
US9056073B2 (en)	2015-06-16
HUP9904408D0 (en)	2000-01-28
EA005198B1 (ru)	2004-12-30
PL201804B1 (pl)	2009-05-29
WO2001037862A3 (fr)	2001-11-22
US20110243990A1 (en)	2011-10-06
SI20960B (sl)	2011-01-31
ES2348591T3 (es)	2010-12-09
DK1272216T3 (da)	2010-09-27
DE60044539D1 (de)	2010-07-22
IL149779A (en)	2009-05-04
CA2394843C (fr)	2011-01-18
UA78673C2 (en)	2007-04-25
PL355886A1 (en)	2004-05-31
HUP9904408A2 (hu)	2002-03-28
RO122760B1 (ro)	2010-01-29
ATE470452T1 (de)	2010-06-15
SK288132B6 (sk)	2013-10-02
HU227086B1 (en)	2010-06-28
EP1272216B1 (fr)	2010-06-09
EA200200602A1 (ru)	2002-10-31
EP1272216A2 (fr)	2003-01-08
SI20960A (sl)	2003-02-28
RS51201B (sr)	2010-12-31
AU779214B2 (en)	2005-01-13
US20160051657A1 (en)	2016-02-25
CZ302662B6 (cs)	2011-08-24
WO2001037862A2 (fr)	2001-05-31
YU37402A (sh)	2005-06-10
AU1874101A (en)	2001-06-04
CZ20021771A3 (cs)	2002-11-13
PT1272216E (pt)	2010-09-14
CA2394843A1 (fr)	2001-05-31
US20080175865A1 (en)	2008-07-24

Publication	Publication Date	Title
MY125387A (en)	2006-07-31	Vaccine
MY119276A (en)	2005-04-30	Pharmaceutical composition for immunomodulation based on peptides and adjuvants
IS5329A (is)	1999-12-29	Flutningskerfi fyrir antígen þar sem monoglýseríðeða díglýseríð afleiður eru ónæmisglæðar
AU5821000A (en)	2001-01-31	Vaccine
AU2535997A (en)	1997-10-10	Prostate specific antigen oligo-epitope peptide
AP2002002445A0 (en)	2002-03-31	Oral recombinant lactobacilli vaccines.
NZ287385A (en)	1998-10-28	Antigenic preparation comprising the catalase of helicobacter bacteria and vaccines used to treat helicobacter infection
IL154913A0 (en)	2003-10-31	Composition comprising immunogenic microparticles
DE60012042D1 (de)	2004-08-12	Entepneumovirus und entsprechendes impfstoff
MXPA02007478A (es)	2004-08-23	Vacuna contra el virus de inmunodeficiencia humana.
AU2001294834A1 (en)	2002-04-08	Recombinant bcg vaccines for the prevention and treatment of cancer
AU8113591A (en)	1992-01-23	Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties
IL149779A0 (en)	2002-11-10	A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias
AU1074902A (en)	2002-05-15	Kahalalide f
WO2000061766A3 (fr)	2001-03-08	Vaccin anticancereux specifique de la telomerase
MXPA02010173A (es)	2003-06-04	Antigenos de leishmania para utilizarse en la terapia y el diagnostico de leishmaniasis.
WO2002076485A3 (fr)	2003-05-30	Vaccin assurant la modulation entre des reponses immunitaires t1 et t2
AU1815899A (en)	1999-06-28	Method and composition to enhance the efficacy of a vaccine using chemokines
WO1997047271A3 (fr)	1998-02-12	Vaccins cellulaires immunotherapeutiques et leurs procedes de preparation
WO2000012122A3 (fr)	2000-06-22	Fragments de l'acide hyaluronique de faible poids moleculaire pour la preparation de vaccins
AU4630700A (en)	2000-12-05	Bacteria strain lactobacillus acidophilus N.V EP 317/402 (narine) AAA used in the production of preparations and of dietetic, therapeutic and prophylactic products for treating dysbacteriosis and the consequences thereof
NZ512850A (en)	2004-01-30	Treatment of papillomavirus infections
AU3991899A (en)	1999-12-06	Verotoxin b subunit for immunization
WO2002038739A3 (fr)	2002-10-24	Expression bacterienne
WO1999002182A3 (fr)	1999-04-01	Vaccins non aqueux